Your browser doesn't support javascript.
loading
In vitro resistance selections using elvitegravir, raltegravir, and two metabolites of elvitegravir M1 and M4.
Margot, Nicolas A; Hluhanich, Rebecca M; Jones, Gregg S; Andreatta, Kristen N; Tsiang, Manuel; McColl, Damian J; White, Kirsten L; Miller, Michael D.
  • Margot NA; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, USA. Electronic address: Nicolas.Margot@gilead.com.
  • Hluhanich RM; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, USA.
  • Jones GS; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, USA.
  • Andreatta KN; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, USA.
  • Tsiang M; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, USA.
  • McColl DJ; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, USA.
  • White KL; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, USA.
  • Miller MD; Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, USA.
Antiviral Res ; 93(2): 288-296, 2012 Feb.
Article en En | MEDLINE | ID: mdl-22197635

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirrolidinonas / Infecciones por VIH / VIH-1 / Quinolonas / Inhibidores de Integrasa VIH / Farmacorresistencia Viral Límite: Humans Idioma: En Año: 2012 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirrolidinonas / Infecciones por VIH / VIH-1 / Quinolonas / Inhibidores de Integrasa VIH / Farmacorresistencia Viral Límite: Humans Idioma: En Año: 2012 Tipo del documento: Article